{"id":"https://genegraph.clinicalgenome.org/r/0a64a38b-4b4e-405c-991a-664ce3559f31v1.0","type":"EvidenceStrengthAssertion","dc:description":"Human pathogenic variants in the Berardinelli-Seip congenital lipodystrophy 2 (*BSCL2*) gene, which encodes a protein called seipin, were first reported in association with congenital generalized lipodystrophy 2 (CGL2) in 2001 (Magre et al, PMID:11479539). We have curated the inheritance pattern for *BSCL2*- related lipodystrophy as autosomal recessive mode of inheritance because, a recessive mode of inheritance has consistently been reported (PMIDs: Jin et al, 18057387, Costa-Riquetto et al, 34033296)\n\nBi-allelic loss-of-function variants, including nonsense, splice site, frame shift and small deletions in the *BSCL2* gene have been reported in individuals with near- complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis, early onset of diabetes, often mild intellectual disability, and in very rare cases, inherited neurological involvement (Celia’s encephalopathy/progressive encephalopathy [PELD], which can also be found in the absence of CGL and is usually caused by variants causing loss of exon 7) (PMIDs: 33916074, 34033296, 29478747, 27144933). Heterozygosity for certain BSCL2 variants believed to cause misfolding of seipin has been implicated in autosomal dominant neurological disorders including Silver spastic paraplegia and distal hereditary motor neuropathy, which do not appear to affect fat metabolism or distribution (PMID:16427281,14981520,18612770).\n\nAt least 30 pathogenic variants (primarily frameshift, nonsense or splice site) in the *BSCL2* gene have been reported in humans with CGL2.   Variants in this gene have been curated in at least 7 probands in 6 publications (PMIDs: 23430896, 18057387, 35351089, 30266686, 30864635, 23659685), with cases presenting as CGL2. More evidence is available to support the gene-disease association in the literature, but as the maximum score for genetic evidence (12 points) has been reached this has not been curated exhaustively. This gene-disease relationship is supported by multiple knockout mouse models that exhibit a similar phenotype and cellular studies on its role in lipid droplet formation (PMID:23989774,18458148,23680914,22269949). Total points for the experimental evidence are 5. The total score for genetic and experimental evidence together are 17.\n\nPer criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in inheritance pattern, mutational mechanism, and phenotype for variants causing congenital generalized lipodystrophy vs. those causing primary neurological conditions. Therefore, we curated *BSCL2* as a lumped curation for autosomal recessive congenital generalized lipodystrophy (OMIM: 269700) and progressive encephalopathy with or without lipodystrophy (OMIM 615924). Autosomal dominant neurological conditions including Silver spastic paraplegia syndrome (OMIM: 270685) and distal hereditary motor neuropathy (OMIM: 619112) will be curated separately in split curations.  \n\nIn summary, *BSCL2* is definitively associated with autosomal recessive congenital generalized lipodystrophy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.\n\nThis classification was approved by the ClinGen Monogenic Diabetes GCEP on November 13, 2024 (SOP Version 11).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/0a64a38b-4b4e-405c-991a-664ce3559f31","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e6b2f631-aedd-4396-8170-a1878ccac459","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e6b2f631-aedd-4396-8170-a1878ccac459_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10016","date":"2024-11-13T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/e6b2f631-aedd-4396-8170-a1878ccac459_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10016","date":"2024-11-14T01:25:33.148Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6b2f631-aedd-4396-8170-a1878ccac459_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6b2f631-aedd-4396-8170-a1878ccac459_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f5b7446-fc8b-45a7-ae0b-7e8b36623bcd_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30864635","rdfs:label":"Lima family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/3f5b7446-fc8b-45a7-ae0b-7e8b36623bcd","type":"Family","rdfs:label":"Lima family","member":{"id":"https://genegraph.clinicalgenome.org/r/752f8f60-0a5f-471b-8725-106b8291bea1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30864635","rdfs:label":"Lima Case","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b2552ea3-db2e-4459-838c-9914b41fa27f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001122955.4(BSCL2):c.517dup (p.Thr173AsnfsTer5)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA277921"}},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/84fd0f11-1ae4-4540-af52-f89903edce26_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30864635","allele":{"id":"https://genegraph.clinicalgenome.org/r/b2552ea3-db2e-4459-838c-9914b41fa27f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0008887","obo:HP_0002155","obo:HP_0001952","obo:HP_0003292","obo:HP_0000855","obo:HP_0000842","obo:HP_0002240"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/752f8f60-0a5f-471b-8725-106b8291bea1"}},{"id":"https://genegraph.clinicalgenome.org/r/7541e676-38bf-4a86-a7ec-fd9fafaf37b4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23659685","rdfs:label":"Rahman family","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/7541e676-38bf-4a86-a7ec-fd9fafaf37b4","type":"Family","rdfs:label":"Rahman family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/46b29342-17ee-4aa7-98ad-c79115a9b689","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23659685","rdfs:label":"Rahman Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3ed50eea-8f1b-4d70-b76d-fd7cf6ab3c50","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001122955.4(BSCL2):c.828del (p.Tyr277ThrfsTer20)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA277929"}},"detectionMethod":"All coding exons including splice junctions of AGPAT2, BSCL2, CAV1 and PTRF genes were PCR amplified and directly sequenced using an automated DNA sequencer ABI3730.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3e8986b0-fc19-4244-826f-f2e47c9e441d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23659685","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ed50eea-8f1b-4d70-b76d-fd7cf6ab3c50"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000956","obo:HP_0001639","obo:HP_0008887","obo:HP_0002155","obo:HP_0000855","obo:HP_0002240"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/46b29342-17ee-4aa7-98ad-c79115a9b689"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1f619f2e-575d-46f4-96c9-f9c9443ed35a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d8e502e-def3-4d84-8fb1-07ab5944e4cd","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d8e502e-def3-4d84-8fb1-07ab5944e4cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35351089","allele":{"id":"https://genegraph.clinicalgenome.org/r/3b75409a-bf04-4d56-bbad-c3311b290fda","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001122955.4(BSCL2):c.985C>T (p.Arg329Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA170512"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1f619f2e-575d-46f4-96c9-f9c9443ed35a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35351089","rdfs:label":"Yang Case","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3b75409a-bf04-4d56-bbad-c3311b290fda"},"detectionMethod":"Sanger sequencing of the entire coding region of the BSCL2 gene was performed","firstTestingMethod":"PCR","phenotypes":["obo:HP_0008887","obo:HP_0000819","obo:HP_0003077","obo:HP_0002240"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4d8e502e-def3-4d84-8fb1-07ab5944e4cd_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/96791b0b-f044-47a0-afe8-18b630b97656_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/016e9ff9-78fa-45b4-a92d-827a1b1cdd0a","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/016e9ff9-78fa-45b4-a92d-827a1b1cdd0a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30266686","allele":{"id":"https://genegraph.clinicalgenome.org/r/3b75409a-bf04-4d56-bbad-c3311b290fda"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5bc11d7c-a8da-4665-803b-52dd02d1e3fa","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5bc11d7c-a8da-4665-803b-52dd02d1e3fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30266686","allele":{"id":"https://genegraph.clinicalgenome.org/r/f1e9dfcd-c6b1-4f19-bffe-6b6364abc5a6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001122955.4(BSCL2):c.402C>G (p.Tyr134Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA380970096"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/96791b0b-f044-47a0-afe8-18b630b97656","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30266686","rdfs:label":"Liu case 5","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/3b75409a-bf04-4d56-bbad-c3311b290fda"},{"id":"https://genegraph.clinicalgenome.org/r/f1e9dfcd-c6b1-4f19-bffe-6b6364abc5a6"}],"detectionMethod":"Whole-exome sequencing was performed on the patient's DNA samples and the suspected pathogenic variant was tested in the parents for familial co-segregation analysis.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0003720","obo:HP_0009059","obo:HP_0001744","obo:HP_0002240"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5bc11d7c-a8da-4665-803b-52dd02d1e3fa_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/016e9ff9-78fa-45b4-a92d-827a1b1cdd0a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/8674393a-ef9e-452d-a563-de4d12c71843_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4d11a93-4b61-4e40-b4a4-f5cdbeaff2ce","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4d11a93-4b61-4e40-b4a4-f5cdbeaff2ce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18057387","allele":{"id":"https://genegraph.clinicalgenome.org/r/92528ce7-9b98-4b24-8696-76a1c7dede6c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001122955.4(BSCL2):c.757G>T (p.Glu253Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA277936"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/8674393a-ef9e-452d-a563-de4d12c71843","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18057387","rdfs:label":"Jin_Case","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/92528ce7-9b98-4b24-8696-76a1c7dede6c"},"detectionMethod":"All coding and intron-exon boundaries for the BSCL2 and AGPAT2 genes were sequenced.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000956","obo:HP_0001433","obo:HP_0007485","obo:HP_0003074","obo:HP_0002240"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d4d11a93-4b61-4e40-b4a4-f5cdbeaff2ce_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/f1fbc104-2d56-48cf-a18a-3796b6fe5fb7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58b93a91-5d1c-444f-863b-527d30184213","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58b93a91-5d1c-444f-863b-527d30184213_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression and subcellular localization studies revealed aberrant sebin proteins with improper cellular localization in U2OS transfected cells.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/58b93a91-5d1c-444f-863b-527d30184213_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23430896","allele":{"id":"https://genegraph.clinicalgenome.org/r/2838984c-822c-4545-826a-59ffc8463204","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001122955.4(BSCL2):c.631-2A>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA380963557"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/f1fbc104-2d56-48cf-a18a-3796b6fe5fb7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23430896","rdfs:label":"Jeninga_case","ageType":"AgeAtDiagnosis","ageUnit":"Days","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2838984c-822c-4545-826a-59ffc8463204"},"detectionMethod":"Genomic DNA was isolated from EDTA containing blood samples. \nExons, including the intron boundaries of BSCL-2, were amplified by PCR and direct sequenced.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002240","obo:HP_0003074","obo:HP_0007485","obo:HP_0003124"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/58b93a91-5d1c-444f-863b-527d30184213_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/752f8f60-0a5f-471b-8725-106b8291bea1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84fd0f11-1ae4-4540-af52-f89903edce26","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84fd0f11-1ae4-4540-af52-f89903edce26_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/752f8f60-0a5f-471b-8725-106b8291bea1"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/c739c9a4-e058-4de2-b1d0-c7bee3957ec7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf08c735-0efb-4ce3-9952-569abc1ac0bb","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf08c735-0efb-4ce3-9952-569abc1ac0bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30266686","allele":{"id":"https://genegraph.clinicalgenome.org/r/598925f0-de1b-40c2-93ba-968099b48a4c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001122955.4(BSCL2):c.759_760del (p.Asn254LeufsTer11)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913190285"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/afea9bb6-ad6d-4d8d-9486-4155b059f0ea","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/afea9bb6-ad6d-4d8d-9486-4155b059f0ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30266686","allele":{"id":"https://genegraph.clinicalgenome.org/r/f90df1c5-3b21-4531-9156-fc6974dbd8ef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001122955.4(BSCL2):c.404+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA380970072"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c739c9a4-e058-4de2-b1d0-c7bee3957ec7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30266686","rdfs:label":"Liu case 2","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/f90df1c5-3b21-4531-9156-fc6974dbd8ef"},{"id":"https://genegraph.clinicalgenome.org/r/598925f0-de1b-40c2-93ba-968099b48a4c"}],"detectionMethod":"Whole-exome sequencing was performed on the patient's DNA samples and the suspected pathogenic variant was tested in the parents for familial co-segregation analysis.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002240","obo:HP_0001744","obo:HP_0003720","obo:HP_0009059"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/afea9bb6-ad6d-4d8d-9486-4155b059f0ea_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cf08c735-0efb-4ce3-9952-569abc1ac0bb_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/46b29342-17ee-4aa7-98ad-c79115a9b689_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e8986b0-fc19-4244-826f-f2e47c9e441d","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e8986b0-fc19-4244-826f-f2e47c9e441d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/46b29342-17ee-4aa7-98ad-c79115a9b689"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/e6b2f631-aedd-4396-8170-a1878ccac459_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6b2f631-aedd-4396-8170-a1878ccac459_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48f924d1-1868-404f-b211-d302ffcfe13d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bae5e918-0aa7-41ee-a2ce-0500eeed4439","type":"Finding","dc:description":"Consistent with the human BSCL2 phenotype, Bscl2−/− mice exhibit seipin deficiency, with severe generalized lipodystrophy, insulin resistance, diabetes, and hepatic steatosis phenotypes, significantly lower circulating leptin and adiponectin levels. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23680914","rdfs:label":"Non-human model organism","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9954be70-ea70-400b-ae17-e8a86bd549fb","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cfe9f694-854d-41f9-bd0e-ec053fb2d9cf","type":"Finding","dc:description":"Bscl2 −/− deficient mice share important pathophysiological features with the phenotype of BSCL2 mutations previously reported in humans, including congenital generalized lipodystrophy and major associated metabolic complications (insulin resistance, impaired glucose tolerance, hepatic steatosis).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22269949","rdfs:label":"Non-human model organism","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a75d78fa-8c6d-4f85-b97b-3ab7f7a1066e","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5cce6c20-50b7-4fbf-abac-1f73c9a7ebc9","type":"Finding","dc:description":"Pioglitazone effectively improves insulin sensitivity, random-fed glucose levels, and hepatic steatosis in Bscl2-/- mice.\n\nRosiglitazone treatment in MEFs enhances adipocyte differentiation and lipolysis rate in sebin-deficient cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23680914","rdfs:label":"TZDs revese the phenotype of Bscl2-/2 mice","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/e6b2f631-aedd-4396-8170-a1878ccac459_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a708ed5-a272-46f3-95bb-1e535cd182c5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e9965e2-acf3-4baa-a7c2-3855609df79f","type":"FunctionalAlteration","dc:description":"R275X shows decreased protein stability and lack of functional protein.  The T78A, L91P and A212P missense mutations do not dramatically alter seipin protein expression, but L91P and A212P seipin show partial mislocalization to the nuclear envelope.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23989774","rdfs:label":"Immunoblotting and Immunofluorescence assay"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e6b2f631-aedd-4396-8170-a1878ccac459_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c83ce868-a983-40fd-9209-a781710bee9a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ece5dc4f-ce4b-4f6d-885d-a38a6473b923","type":"Finding","dc:description":"BSCL2 is highly expressed in adipose tissue and is involved in the regulation of adipocyte differentiation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18458148","rdfs:label":"Real-time PCR","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":9333,"specifiedBy":"GeneValidityCriteria11","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/umEP3luU7y4","type":"GeneValidityProposition","disease":"obo:MONDO_0006573","gene":"hgnc:15832","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e6b2f631-aedd-4396-8170-a1878ccac459-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}